Skip to main content
Top
Published in: Breast Cancer Research 2/2009

01-10-2009 | Poster presentation

Can we predict the likelihood of malignancy in mammographically indeterminate microcalcification?

Authors: AN Khan, M Hoosein, N Hartley, S Tennant, H Daintith, E Denton, M Al-Attar

Published in: Breast Cancer Research | Special Issue 2/2009

Login to get access

Excerpt

The aim of this study was to identify features that will enable a radiologist to predict the likelihood of malignancy in mammographically indeterminate microcalcification (M3) before biopsy. …
Metadata
Title
Can we predict the likelihood of malignancy in mammographically indeterminate microcalcification?
Authors
AN Khan
M Hoosein
N Hartley
S Tennant
H Daintith
E Denton
M Al-Attar
Publication date
01-10-2009
Publisher
BioMed Central
Published in
Breast Cancer Research / Issue Special Issue 2/2009
Electronic ISSN: 1465-542X
DOI
https://doi.org/10.1186/bcr2393

Other articles of this Special Issue 2/2009

Breast Cancer Research 2/2009 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine